A unique circulating microRNA pairs signature serves as a superior tool for early diagnosis of pan-cancer
View abstract on PubMed
Summary
This summary is machine-generated.A new machine learning model using 31 microRNA pairs (31-miRP) offers highly accurate pan-cancer diagnosis. This novel signature shows strong potential for early cancer detection and clinical application due to its high specificity and sensitivity.
Area Of Science
- Oncology
- Genomics
- Bioinformatics
Background
- Cancer diagnosis relies heavily on early detection for improved patient outcomes.
- Current microRNA (miRNA)-based diagnostic signatures often lack precise cutoff values, limiting clinical utility.
- Developing robust and reliable biomarkers for pan-cancer diagnosis is a global health priority.
Purpose Of The Study
- To develop an innovative, machine learning-driven microRNA pairwise (miRP) signature for accurate pan-cancer diagnosis.
- To establish a signature with a precise cutoff value for enhanced clinical applicability.
- To evaluate the diagnostic performance of the developed signature against existing methods.
Main Methods
- Analysis of miRNA expression profiles from 15,832 patients across 13 cancer types and 10 cohorts.
- Utilized five machine learning algorithms (XGBoost, SVM, RandomForest, LASSO, Logistic) for signature construction.
- Optimized the signature using Area Under the Curve (AUC) and Youden index, comparing it with 25 previously published signatures.
Main Results
- A Random Forest-based signature comprising 31 microRNA pairs (31-miRP) demonstrated high diagnostic efficiency (AUC: 0.980-1.000) across diverse datasets and cancer types.
- The 31-miRP signature showed excellent performance in early-stage cancer diagnosis (AUC: 0.961-0.998).
- The signature effectively differentiated cancers from normal tissues (AUC: 0.976-0.998) and benign lesions, outperforming 25 existing signatures.
Conclusions
- The 31-miRP signature serves as a powerful and reliable tool for pan-cancer diagnosis.
- This signature exhibits high specificity and sensitivity, with a clear cutoff value, facilitating early cancer detection.
- The developed 31-miRP signature holds significant potential for clinical translation in early cancer diagnosis.
Related Concept Videos
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

